Montpellier, France

Cédric Bes

This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cédric Bes. Retrieved from https://idiyas.com/inventor/cédric-bes-ratr150v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Cédric Bes: Pioneering Advances in Antibody Technology

Introduction

Cédric Bes is a notable inventor based in Montpellier, France, recognized for his contributions to the field of biotechnology. His innovative work primarily focuses on antibody development and applications that may significantly impact medical therapies.

Latest Patents

One of Cédric Bes's key patents is titled "Mutant Fab fragments of the chimeric 13B8.2 anti-CD4 antibody and their applications." This patent describes a mutant Fab fragment of the 13B8.2 anti-CD4 antibody, which binds effectively to the CD4 molecule. The invention features a mutation of at least one residue located within the VH variable domain of the heavy chain and/or the VL variable domain of the light chain, enhancing its functionality in therapeutic applications.

Career Highlights

Cédric Bes has established himself as a valuable contributor to research and innovation through his role at the Centre National de la Recherche Scientifique (CNRS). His work emphasizes the intersection of science and practical applications, showcasing his commitment to advancing biotechnological frontiers.

Collaborations

Throughout his career, Cédric has collaborated with esteemed colleagues, including Christian Devaux and Laurence Briant-Longuet. These partnerships have fostered an environment of shared expertise and innovation, further strengthening the impact of their collective work in the field of antibody research.

Conclusion

Cédric Bes's innovative contributions to antibody technology reflect a dedication to scientific progress and medical application. As he continues to work at the CNRS, his ongoing research and collaborations are likely to pave the way for future advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…